Rankings
▼
Calendar
▼
TLX Q4 1999 Earnings Report — Telix Pharmaceuticals Limited Revenue & Financial Results | Market Cap Arena
Telix Pharmaceuticals Limited
TLX
Q4 1999 Earnings
Reported January 30, 2000
Quarter Comparison
Revenue
Operating Income
EPS (Diluted)
Metric
Q4 1999
Q3 1999
Q4 1998
QoQ Change
YoY Change
Revenue
$0
—
$0
—
—
Op. Income
-$177.6K
—
-$103.3K
—
-72.0%
EPS (Diluted)
$0.00
—
$0.00
—
NaN%
marketcaparena.com
Income Statement
Item
Amount
REVENUE
$0
Cost of Revenue
$0
GROSS PROFIT
$0
R&D Expenses
$0
Selling & Marketing
$0
General & Administrative
$0
SG&A Expenses
$0
Other Expenses
-$177.6K
Operating Expenses
-$177.6K
Cost & Expenses
-$177.6K
OPERATING INCOME
-$177.6K
Interest Income
$0
Interest Expense
$0
Other Income/Expenses
$88.8K
INCOME BEFORE TAX
-$88.8K
Income Tax Expense
-$88.8K
Net Income from Continuing Ops
$0
Net Income from Discontinued Ops
$0
Other Adjustments
$0
NET INCOME
$0
Net Income Deductions
$0
BOTTOM LINE NET INCOME
$0
D&A
$0
EBIT
$0
EBITDA
-$177.6K
EPS
$0
EPS Diluted
$0
marketcaparena.com
← FY 1999
TLX Overview
Q2 2000 →